-

Lost Money in The Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of The Chemours Company (“Chemours”) dropped over 12% in intraday trading on February 14, 2024, after announcing it is evaluating its internal control over financial reporting and postponing its fourth quarter and full year 2023 financial results. Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).

What Should Chemours Company Investors Do?

If you invested in The Chemours Company, visit our website by clicking here, or call us toll-free at (888) 410-2925 to discuss how you may be able to recover your losses. Our investigation concerns whether Chemours Company has violated federal securities laws by providing false or misleading statements to investors.

What is The Chemours Company Securities Lawsuit Investigation About?

After the market closed on February 13, 2024, Chemours announced that it is delaying the release of its fourth quarter and full year 2023 financial results in part because it needs to evaluate its internal control over financial reporting as of December 31, 2023. According to the announcement, these financial results were previously scheduled to be released on February 14, 2024, and February 15, 2024, and have been delayed until after the market close on Wednesday, February 28, 2024. The company also disclosed that these financial results are delayed in part because the company’s Audit Committee requires additional time for internal review.

Following Chemours’ announcement, the stock dropped over 12% in intraday trading on February 14th, causing harm to investors.

About Gibbs Law Group

Gibbs Law Group represents investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

Gibbs Law Group

NYSE:CC

Release Summary
Gibbs Law Group is investigating potential legal claims on behalf of Chemours Company (NYSE: CC) investors. Call (888) 410-2925.
Release Versions
$Cashtags
Hashtags

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

More News From Gibbs Law Group

Lost Money in Hub Group (NASDAQ: HUBG)? Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Hub Group Inc. (HUBG) investors....

Lost Money in Inspired Healthcare Capital? Gibbs Mura & Silver Law Group Are Investigating Legal Claims on Behalf of Inspired Healthcare Capital (IHC) Private Placement Investors

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating legal claims on behalf of Inspired Healthcare Capital (IHC) investors. IHC, the senior living-focused private equity company, filed for Chapter 11 bankruptcy on February 2, 2026, reporting between $1-10 billion dollars in liabilities. Our IHC Bankruptcy Lawsuit Investigation may include legal claims against brokerage firms who recommended IHC private placements to investors. Invested in Inspired Healthcare Capital (IHC)? Call our Fin...

Class Action Lawsuit Filed Against Richtech Robotics; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces a class action lawsuit has been filed on behalf of Richtech Robotics Inc. (RR) investors....
Back to Newsroom